glucagon has been researched along with 4-diphenylacetoxy-1,1-dimethylpiperidinium in 1 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (4-diphenylacetoxy-1,1-dimethylpiperidinium) | Trials (4-diphenylacetoxy-1,1-dimethylpiperidinium) | Recent Studies (post-2010) (4-diphenylacetoxy-1,1-dimethylpiperidinium) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 446 | 1 | 52 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahrén, B; Karlsson, S; Sundler, F | 1 |
1 other study(ies) available for glucagon and 4-diphenylacetoxy-1,1-dimethylpiperidinium
| Article | Year |
|---|---|
Insulin secretion by gastrin-releasing peptide in mice: ganglionic versus direct islet effect.
Topics: Animals; Blood Glucose; Capsaicin; Cells, Cultured; Female; Ganglia, Sympathetic; Gastrin-Releasing Peptide; Glucagon; Hexamethonium; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Mice, Inbred Strains; Muscarinic Antagonists; Pancreas; Piperidines; Receptor, Muscarinic M3; Receptors, Muscarinic | 1998 |